HER2/neu (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "HER2/neu" in Serbian language version.

refsWebsite

Global rank Serbian rank

20nih.gov

4^th place

8^th place

18doi.org

2^nd place

4^th place

2archive.org

6^th place

5^th place

1harvard.edu

18^th place

28^th place

archive.org

Olayioye MA, Graus-Porta D, Beerli RR, Rohrer J, Gay B, Hynes NE (1998). „ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner”. Molecular and Cellular Biology. 18 (9): 5042—51. PMC 109089 . PMID 9710588. doi:10.1128/mcb.18.9.5042.
Peles E, Levy RB, Or E, Ullrich A, Yarden Y (1991). „Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma”. The EMBO Journal. 10 (8): 2077—86. PMC 452891 . PMID 1676673.

doi.org

Mitri Z, Constantine T, O'Regan R (2012). „The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy”. Chemother Res Pract. 2012: 743193. PMC 3539433 . PMID 23320171. doi:10.1155/2012/743193.
Burstein HJ (2005). „The distinctive nature of HER2-positive breast cancers”. N. Engl. J. Med. 353 (16): 1652—4. PMID 16236735. doi:10.1056/NEJMp058197.
Schroeder JA, Adriance MC, McConnell EJ, Thompson MC, Pockaj B, Gendler SJ (2002). „ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas”. The Journal of Biological Chemistry. 277 (25): 22692—8. PMID 11950845. doi:10.1074/jbc.M201975200.
Kanai Y, Ochiai A, Shibata T, Oyama T, Ushijima S, Akimoto S, Hirohashi S (1995). „c-erbB-2 gene product directly associates with beta-catenin and plakoglobin”. Biochemical and Biophysical Research Communications. 208 (3): 1067—72. PMID 7702605. doi:10.1006/bbrc.1995.1443.
Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS, Pelkey KA, Yang DJ, Xiong WC, Salter MW, Mei L (2000). „Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses”. Neuron. 26 (2): 443—55. PMID 10839362. doi:10.1016/s0896-6273(00)81176-9.
Jaulin-Bastard F, Saito H, Le Bivic A, Ollendorff V, Marchetto S, Birnbaum D, Borg JP (2001). „The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins”. The Journal of Biological Chemistry. 276 (18): 15256—63. PMID 11278603. doi:10.1074/jbc.M010032200.
Bilder D, Birnbaum D, Borg JP, Bryant P, Huigbretse J, Jansen E, Kennedy MB, Labouesse M, Legouis R, Mechler B, Perrimon N, Petit M, Sinha P (2000). „Collective nomenclature for LAP proteins”. Nature Cell Biology. 2 (7): E114. doi:10.1038/35017119.
Huang YZ, Zang M, Xiong WC, Luo Z, Mei L (2003). „Erbin suppresses the MAP kinase pathway”. The Journal of Biological Chemistry. 278 (2): 1108—14. PMID 12379659. doi:10.1074/jbc.M205413200.
Schulze WX, Deng L, Mann M (2005). „Phosphotyrosine interactome of the ErbB-receptor kinase family”. Molecular Systems Biology. 1: 2005.0008. PMC 1681463 . PMID 16729043. doi:10.1038/msb4100012.
Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA, Hung MC (2001). „Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth”. The Journal of Biological Chemistry. 276 (52): 48679—92. PMID 11606575. doi:10.1074/jbc.M106759200.
Olayioye MA, Graus-Porta D, Beerli RR, Rohrer J, Gay B, Hynes NE (1998). „ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner”. Molecular and Cellular Biology. 18 (9): 5042—51. PMC 109089 . PMID 9710588. doi:10.1128/mcb.18.9.5042.
Xu W, Mimnaugh E, Rosser MF, Nicchitta C, Marcu M, Yarden Y, Neckers L (2001). „Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90”. The Journal of Biological Chemistry. 276 (5): 3702—8. PMID 11071886. doi:10.1074/jbc.M006864200.
Jeong JH, An JY, Kwon YT, Li LY, Lee YJ (2008). „Quercetin-induced ubiquitination and down-regulation of Her-2/neu”. Journal of Cellular Biochemistry. 105 (2): 585—95. PMC 2575035 . PMID 18655187. doi:10.1002/jcb.21859.
Grant SL, Hammacher A, Douglas AM, Goss GA, Mansfield RK, Heath JK, Begley CG (2002). „An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells”. Oncogene. 21 (3): 460—74. PMID 11821958. doi:10.1038/sj.onc.1205100.
Schroeder JA, Thompson MC, Gardner MM, Gendler SJ (2001). „Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland”. The Journal of Biological Chemistry. 276 (16): 13057—64. PMID 11278868. doi:10.1074/jbc.M011248200.
Gout I, Dhand R, Panayotou G, Fry MJ, Hiles I, Otsu M, Waterfield MD (1992). „Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 beta protein by using the baculovirus expression system”. The Biochemical Journal. 288 ( Pt 2) (2): 395—405. PMC 1132024 . PMID 1334406. doi:10.1042/bj2880395.
Arteaga CL, Johnson MD, Todderud G, Coffey RJ, Carpenter G, Page DL (1991). „Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas”. Proceedings of the National Academy of Sciences of the United States of America. 88 (23): 10435—9. Bibcode:1991PNAS...8810435A. PMC 52943 . PMID 1683701. doi:10.1073/pnas.88.23.10435.
Wong L, Deb TB, Thompson SA, Wells A, Johnson GR (1999). „A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling”. The Journal of Biological Chemistry. 274 (13): 8900—9. PMID 10085134. doi:10.1074/jbc.274.13.8900.

harvard.edu

adsabs.harvard.edu

Arteaga CL, Johnson MD, Todderud G, Coffey RJ, Carpenter G, Page DL (1991). „Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas”. Proceedings of the National Academy of Sciences of the United States of America. 88 (23): 10435—9. Bibcode:1991PNAS...8810435A. PMC 52943 . PMID 1683701. doi:10.1073/pnas.88.23.10435.

nih.gov

ncbi.nlm.nih.gov

Mitri Z, Constantine T, O'Regan R (2012). „The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy”. Chemother Res Pract. 2012: 743193. PMC 3539433 . PMID 23320171. doi:10.1155/2012/743193.
Burstein HJ (2005). „The distinctive nature of HER2-positive breast cancers”. N. Engl. J. Med. 353 (16): 1652—4. PMID 16236735. doi:10.1056/NEJMp058197.
Schroeder JA, Adriance MC, McConnell EJ, Thompson MC, Pockaj B, Gendler SJ (2002). „ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas”. The Journal of Biological Chemistry. 277 (25): 22692—8. PMID 11950845. doi:10.1074/jbc.M201975200.
Bonvini P, An WG, Rosolen A, Nguyen P, Trepel J, Garcia de Herreros A, Dunach M, Neckers LM (2001). „Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription”. Cancer Research. 61 (4): 1671—7. PMID 11245482.
Kanai Y, Ochiai A, Shibata T, Oyama T, Ushijima S, Akimoto S, Hirohashi S (1995). „c-erbB-2 gene product directly associates with beta-catenin and plakoglobin”. Biochemical and Biophysical Research Communications. 208 (3): 1067—72. PMID 7702605. doi:10.1006/bbrc.1995.1443.
Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS, Pelkey KA, Yang DJ, Xiong WC, Salter MW, Mei L (2000). „Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses”. Neuron. 26 (2): 443—55. PMID 10839362. doi:10.1016/s0896-6273(00)81176-9.
Jaulin-Bastard F, Saito H, Le Bivic A, Ollendorff V, Marchetto S, Birnbaum D, Borg JP (2001). „The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins”. The Journal of Biological Chemistry. 276 (18): 15256—63. PMID 11278603. doi:10.1074/jbc.M010032200.
Huang YZ, Zang M, Xiong WC, Luo Z, Mei L (2003). „Erbin suppresses the MAP kinase pathway”. The Journal of Biological Chemistry. 278 (2): 1108—14. PMID 12379659. doi:10.1074/jbc.M205413200.
Schulze WX, Deng L, Mann M (2005). „Phosphotyrosine interactome of the ErbB-receptor kinase family”. Molecular Systems Biology. 1: 2005.0008. PMC 1681463 . PMID 16729043. doi:10.1038/msb4100012.
Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA, Hung MC (2001). „Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth”. The Journal of Biological Chemistry. 276 (52): 48679—92. PMID 11606575. doi:10.1074/jbc.M106759200.
Olayioye MA, Graus-Porta D, Beerli RR, Rohrer J, Gay B, Hynes NE (1998). „ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner”. Molecular and Cellular Biology. 18 (9): 5042—51. PMC 109089 . PMID 9710588. doi:10.1128/mcb.18.9.5042.
Xu W, Mimnaugh E, Rosser MF, Nicchitta C, Marcu M, Yarden Y, Neckers L (2001). „Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90”. The Journal of Biological Chemistry. 276 (5): 3702—8. PMID 11071886. doi:10.1074/jbc.M006864200.
Jeong JH, An JY, Kwon YT, Li LY, Lee YJ (2008). „Quercetin-induced ubiquitination and down-regulation of Her-2/neu”. Journal of Cellular Biochemistry. 105 (2): 585—95. PMC 2575035 . PMID 18655187. doi:10.1002/jcb.21859.
Grant SL, Hammacher A, Douglas AM, Goss GA, Mansfield RK, Heath JK, Begley CG (2002). „An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells”. Oncogene. 21 (3): 460—74. PMID 11821958. doi:10.1038/sj.onc.1205100.
Li Y, Yu WH, Ren J, Chen W, Huang L, Kharbanda S, Loda M, Kufe D (2003). „Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein”. Molecular Cancer Research. 1 (10): 765—75. PMID 12939402.
Schroeder JA, Thompson MC, Gardner MM, Gendler SJ (2001). „Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland”. The Journal of Biological Chemistry. 276 (16): 13057—64. PMID 11278868. doi:10.1074/jbc.M011248200.
Gout I, Dhand R, Panayotou G, Fry MJ, Hiles I, Otsu M, Waterfield MD (1992). „Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 beta protein by using the baculovirus expression system”. The Biochemical Journal. 288 ( Pt 2) (2): 395—405. PMC 1132024 . PMID 1334406. doi:10.1042/bj2880395.
Peles E, Levy RB, Or E, Ullrich A, Yarden Y (1991). „Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma”. The EMBO Journal. 10 (8): 2077—86. PMC 452891 . PMID 1676673.
Arteaga CL, Johnson MD, Todderud G, Coffey RJ, Carpenter G, Page DL (1991). „Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas”. Proceedings of the National Academy of Sciences of the United States of America. 88 (23): 10435—9. Bibcode:1991PNAS...8810435A. PMC 52943 . PMID 1683701. doi:10.1073/pnas.88.23.10435.
Wong L, Deb TB, Thompson SA, Wells A, Johnson GR (1999). „A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling”. The Journal of Biological Chemistry. 274 (13): 8900—9. PMID 10085134. doi:10.1074/jbc.274.13.8900.